Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg

Clinical trial NCT00003789 · COMPLETED

Trial details

NCT number: NCT00003789
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Melanoma Stage III Melanoma

Start date: 1999-03-01
Primary completion: 2004-01-01
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.